Speaker illustration

Associate Professor Per Johanson

AstraZeneca R&D, Gothenburg (Sweden)

Member of:

European Society of Cardiology

Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved european label: insights from PEGASUS-TIMI 54

Event: ESC Congress 2017

Topic: Thrombosis and platelets

Session: Acute coronary syndromes


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb